E3 ligase Ligand 8
CAS No. 1225383-33-4
E3 ligase Ligand 8 ( —— )
Catalog No. M23396 CAS No. 1225383-33-4
E3 ligase Ligand 8 is a ligand for E3 ubiquitin ligase. E3 ligase Ligand 8 can be connected to the ligand for protein by a linker to form PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 32 | In Stock |
|
10MG | 50 | In Stock |
|
25MG | 102 | In Stock |
|
50MG | 170 | In Stock |
|
100MG | 282 | In Stock |
|
500MG | 691 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameE3 ligase Ligand 8
-
NoteResearch use only, not for human use.
-
Brief DescriptionE3 ligase Ligand 8 is a ligand for E3 ubiquitin ligase. E3 ligase Ligand 8 can be connected to the ligand for protein by a linker to form PROTACs.
-
DescriptionE3 ligase Ligand 8 is a ligand for E3 ubiquitin ligase. E3 ligase Ligand 8 can be connected to the ligand for protein by a linker to form PROTACs. PROTACs are inducers of ubiquitination-mediated degradation of cancer-promoting proteins.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1225383-33-4
-
Formula Weight530.6
-
Molecular FormulaC31H34N2O6
-
Purity>98% (HPLC)
-
SolubilityDMSO: 90 mg/mL (169.62 mM; Need ultrasonic)
-
SMILESCC(C)C[C@@H](C(O)=O)NC([C@@H](O)[C@H](NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)CC4=CC=CC=C4)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shibata N, et al. Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands. J Med Chem. 2018 Jan 25;61(2):543-575.
molnova catalog
related products
-
Avatrombopag
Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platelet production.
-
PACAP (6-38), human,...
PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively.
-
2-Methylbenzhydrol
Used as pharmaceutical intermediates.